Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas

Experimental Hematology

Volumn 27, Issue 7, 1999, Pages 1185-1193

  Chaperot, Laurence ^a,b   Delfau Larue, Marie Hélène ^c,d   Jacob, Marie Christine ^a,b   Molens, Jean Paul ^a,b   Roussel, Bernard ^a   Agrawal, Samir ^c,e   Farcet, Jean Pierre ^c,e   Gressin, Rémy ^b   Sotto, Jean Jacques ^b   Bensa, Jean Claude ^a,b   Plumas, Joël ^a,b  

^a Research Group on Lymphomas   (France)

^b Research Group on Lymphomas   (France)

^c Immunology Laboratory   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e INSERM   (France)

Author keywords

B lymphocytes; CTL; Cytokines; Cytotoxicity; Lymphoma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MEMORY CELL; NONHODGKIN LYMPHOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0032982932     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00057-0     Document Type: Article

References (41)

1. Gisselbrecht C., Maraninchi D., Pico J.L., Milpied N., Coiffier B., Divine M., Tiberghien P., Bosly A., Tilly H., Boulat O., Brandely M. Interleukin-2 treatment in lymphoma. a phase II multicenter study Blood. 83:1994;2081.
2. Weber J.S., Yang J.C., Topalian S.L., Schwartzentruber D.J., White D.E., Rosenberg S.A. The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. J Clin Oncol. 10:1992;33.
3. Horning S.J. Treatment approaches to the low-grade lymphomas. Blood. 83:1994;881.
4. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:1996;52.
5. Nelson E.L., Li X., Hsu F.J., Kwak L.W., Levy R., Clayberger C., Krensky A.M. Tumor specific cytotoxic T-lymphocyte response after idiotype vaccination for B-cell non-Hodgkin's lymphoma. Blood. 88:1996;580.
6. Shi I., Bonnefoix T., Heuzelevacon F., Jacob M.C., Leroux D., Gressin R., Sotto M.F., Chaffanjon P., Bensa J.C., Sotto J.J. Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-hodgkin's lymphomas. Br J Haematol. 90:1995;837.
7. Jacob M.C., Piccini M.P., Bonnefoix T., Sotto M.F., Couderc P., Bensa J.C., Sotto J.J. T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma. reactivity toward the malignant clone Blood. 75:1990;1154.
8. Schwartzentruber D.J., Steler-Stevenson M., Rosenberg S.A., Topalian S.L. Tumor-infiltrating lymphocytes from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α in response to autologous tumor stimulation. Blood. 82:1993;1204.
9. Krieger J.I., Grammer S.F., Grey H.M., Chesnut R.W. Antigen presentation by splenic B cells. resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses J Immunol. 135:1985;2937.
10. Plumas J., Chaperot L., Jacob M.C., Giroux C., Mollens J.P., Sotto J.J., Bensa J.C. Malignant B lymphocytes induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures. Eur J Immunol. 25:1995;3332.
11. Chaperot L., Plumas J., Jacob M.-C., Bost F., Molens J.-P., Sotto J.-J., Bensa J.-C. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphoma. Exp Hematol. 24:1999;479.
12. Plumas J., Jacob M.C., Chaperot L., Molens J.P., Sotto J.J., Bensa J.C. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood. 91:1998;2875.
13. Heslop H.E., Ng C.Y.C., Li C., Smith C.A., Loftin S.K., Krance R.A., Brenner M.K., Rooney C.M. Long term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med. 2:1996;551.
14. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., Dewolfpeeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Mullerhermelink H.K., Pileri S.A., Piris M.A., Ralfkiaer E., Warnke R.A. A revised european-american classification of lymphoid neoplasms. a proposal from the international lymphoma study group Blood. 84:1994;1361.
15. Theodorou I., Bigorne C., Delfau M.-H., Lahet C., Cochet G., Vidaud M., Raphael M., Gaulard P., Farcet J.-P. VJ rearrangements of the TCRg locus in peripheral T-cell lymphomas. analysis by polymerase chain reaction and denaturing gradient gel electrophoresis J Pathol. 178:1996;303.
16. Constant P., Davodeau F., Peyrat M.-A., Poquet Y., Puzo G., Bonneville M., Fournié J.-J. Stimulation of human gamma-delta T cells by nonpeptidic mycobacterial ligands. Science. 264:1994;267.
17. Bromberg J.S., Chavin K., Kundel S. Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. J Immunol. 148:1992;3412.
18. Barth R.J. Jr., Mule J.J., Spiess P.J., Rosenberg S.A. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med. 173:1991;647.
19. Tuttle T., McCrady C.W., Inge T.H., Salour M., Bear H.D. Gamma-interferon plays a key role in T-cell-induced tumor regression. Cancer Res. 53:1993;833.
20. Young M.R.I., Mccloskey G., Wright M.A., Pak A.S. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte macrophage progenitor cells with low doses of interferon gamma-plus tumor necrosis factor-alpha. Cancer Immunol Immunother. 38:1994;9.
21. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 89:1992;1890.
22. Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med. 173:1991;705.
23. O'Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., Barbis D., Stall A., Cupp J., Moore K., Vieira P., Mosmann T., Whitmore A., Arnold L., Haughton G., Howard M. Production of cytokines by mouse B cells. B lymphomas and normal B cells produce interleukin 10 Int Immunol. 2:1990;821.
24. Howard M., O'Garra A. Biological properties of interleukin 10. Immunol Today. 13:1992;198.
25. Chaperot L., Jacob M.-C., Le Vacon F., Giroux C., Molens J.-P., Sotto J.-J., Bensa J.-C., Plumas J. Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and adhesion molecules expression in non Hodgkin's lymphomas. Leuk Lymphoma. 28:1997;133.
26. Freedman A.S. Expression and function of adhesion receptors on normal B-cells and B-cell non-Hodgkin's lymphomas. Semin Hematol. 30:1993;318.
27. Kudoh S., Wang Q., Hidalgo O.F., Rayman P., Tubbs R.R., Edinger M.G., Kolenko V., Panuto J., Bukowski R., Finke J.H. Responses to T cell receptor CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non Hodgkin's lymphomas. Cancer Immunol Immunother. 41:1995;175.
28. Wang Q., Stanley J., Kudoh S., Myles J., Kolenko V., Yi T.L., Tubbs R., Bukowski R., Finke J. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol. 155:1995;1382.
29. Trinchieri G. Interleukin-12. a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood. 84:1994;4008.
30. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.A., Wolf S., Young D., Clark S.C., Trincheri G. Induction of IFN-γ production by NK cell stimulatory factor. characterization of the responder cells and synergy with other inducers J Exp Med. 173:1991;896.
31. Gately M.K., Wolitzky A.G., Quinn P.M., Chizzonite R. Regulation of human cytolytic lymphocyte responses by IL-12. Cell Immunol. 143:1992;127.
32. Zeh H.J., Hurd S., Storkus W.J., Lotze M.T. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors - implications for the immunotherapy of cancer. J Immunother. 14:1993;155.
33. Durum S.K., Schmidt J.A., Oppenheim J.J. Interleukin 1. an immunological perspective Ann Rev Immunol. 3:1985;263.
34. Schultze J.L., Seamon M.J., Michalak S., Gribben J.G., Nadler L.M. Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. Blood. 89:1997;3806.
35. Windhagen A., Anderson D.E., Carrizosa A., Williams R.E., Hafler D.A. IL-12 induces human T cells secreting IL-10 with IFN-gamma. J Immunol. 157:1996;1127.
36. Gerosa F., Paganin C., Peritt D., Paiola F., Scupoli M.T., Aste Amezaga M., Frank I., Trinchieri G. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med. 183:1996;2559.
37. Meyaard L., Hovenkamp E., Otto S.A., Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol. 156:1996;2776.
38. Jeannin P., Delneste Y., Seveso M., Life P., Bonnefoy J.Y. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol. 156:1996;3159.
39. Rathmell J.C., Townsend S.E., Xu J.C., Flavell R.A., Goodnow C.C. Expansion or elimination of B cells in vivo. dual roles for CD40 and Fas (CD95) ligands modulated by the B cell antigen receptor Cell. 87:1996;319.
40. Umetsu D.T., Esserman L., Donlon T.A., DeKruyff R.H., Levy R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol. 144:1990;2550.
41. Schwaller J., Tobler A., Niklaus G., Hurwitz N., Hennig I., Fey M.F., Borisch B. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. Blood. 85:1995;2182.